Recent Grants:

Updating PRISMA Guidance for Network Meta-Analysis, Scoping Reviews and Rapid Reviews (Co-PI; $416,925, CIHR, 2023-2025).

Environmental Sustainability in Healthcare (with a Focus on Pharmacies): A Series of Scoping Reviews (Co-PI; $100,000, CIHR, 2023-24).

Using case-finding algorithms on routinely collected administrative data to identify study outcomes in patients with early-stage breast cancer (REaCT-ZELDA). (Co-PI, TOHAMO. 2023-24, $100,000).

Developing a case-finding algorithm for patients with lymphoma using routinely collected administrative data to identify relapse of disease (Co-PI, TOHAMO. 2024-25, $100,000).

Operating Grant: The SPOR Evidence Alliance for Guidelines and Systematic Reviews (Co-I, $1,380,000, CIHR, 2024-25).

Knowledge syntheses to identify best treatments for chemotherapy related neurocognitive dysfunction in cancer survivors (Nominated PI. $99,450, CIHR. 2022-2024).

Evaluating the Benefits of Rapid Access Addiction Medicine Clinics for Problematic Alcohol Use: A Retrospective Cohort Study to Inform Policy, Practice, and Future Research (co-PI, $99,700, CIHR. 2022-2023).

The Canadian Prehabilitation Network Review: a systematic review and component network meta-analysis to inform prehabilitation design and evaluation (Co-PI, $100,000, CIHR. 2022-23).

Strategy for Patient-Oriented Research (SPOR) Evidence Alliance, Canadian Institutes of Health Research (CIHR), Operating Grant: SPOR – Guidelines and Systematic Reviews - Extension and Renewal (Co-investigator, $2,630,000, CIHR. 2022-23).

Intraoperative pharmacologic opioid minimization strategies and patient-centred outcomes after surgery: a scoping review (Co-investigator, $100,000, CIHR. 2022-23)

Examining the downstream health impacts associated with emergency room visits for alcohol intoxication in youth and young adults (Co-Investigator, $100,000, CIHR. 2022-23).

Synthetic Data Generation to Enable Rapid and Broad Access to 3 Large Clinical Trial Datasets (Co-Investigator, $95,842, Canadian Cancer Society. 2022-24).

 Models for Primary Medical Care, Nursing Care and Personal Care in Long-Term Care Homes: Systematic Reviews to Inform Change in Canada (Canadian Institutes of Health Research, 2021-2023: $126,000). Role: Co-PI.

An umbrella review of prehabilitation interventions in surgery to inform policy and practice (Canadian Institutes of Health Research, 2021: $100,000). Role: Co-PI.

The development of a risk of bias assessment tool for network meta-analysis (Canadian Institutes of Health Research, 2021-24: $360, 116). Role: Co-I.

RESILIENCE (RESponsive Inquiry Linking IntervENtions and Caregiving Experiences) (Canadian Institutes of Health Research, 2021-22: $100,000). Role: Co-I.

Scoping Review of Evidence Regarding Psychosocial and Pharmacologic Interventions for Methamphetamine Use Disorder and Problematic Methamphetamine Use: Planning and Prioritizing Future Research (Canadian Institutes of Health Research, 2020: $99,240). Role: PI. 

Artificial Intelligence in Systematic Reviews: Evaluation of Emerging Electronic Tools for Researchers in Knowledge Synthesis (Canadian Institutes of Health Research, 2019: $100,000). Role: PI.

CIHR Drug Safety and Effectiveness Network Team Grant: Methods and Applications Group for Indirect Comparisons (MAGIC) (Canadian Institutes of Health Research: 2019-2021: $5,000,000). Role: Co-PI.

Evaluating the Health Effects of Medical and Non-Medical Cannabis Use in the Elderly (Canadian Institutes of Health Research, 2019: $122,626). Role: PI.

Evaluating Ontario's rapid access addiction medicine (RAAM) model of care to address the Canadian opioid crisis (Canadian Institutes of Health Research, 2019: $97,000). Role: Co-PI.

Establishing an International Core Outcome Set for Clinical Trials of Interventions for Venous Thromboembolism in Adults (VTE-COS) (Canadian Institutes of Health Research, 2019: $250,000). Role: Co-investigator.

Using Real-World Data and Iterative Economic Evaluation to Prioritize Resource Allocation for Care and Research in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (Ontario Institute for Cancer Research, 2019: $285,000). Role: Co-investigator.

Does integration of the Predict 2.1 algorithm into routine clinical practice improve the value of multigene assays in early stage breast cancer patients? A prospective cohort study with a pre-versus post-comparison (Ontario Institute for Cancer Research, 2019: $260,000). Role: Co-investigator.

Comparing Psychosocial Interventions and Establishing Core Outcomes for Opioid Use Disorder (Canadian Institutes of Health Research, 2018; $108,100). Role: PI.

Signal detection and network meta-analyses to update Canadian guidelines for chronic sinusitus (Canadian Institutes of Health Research, 2018-2020; $190,000). Role: PI.

Decision coaching for people preparing to make health decisions: A systematic review using an integrated knowledge translation approach (Canadian Institutes of Health Research, 2019-2021; $150,000). Role: Co-PI.

Randomised Study Comparing No Mechanical Bowel Preparation with Oral Antibiotics Alone in Patients Undergoing Elective Colon Surgery (The Ottawa Hospital Academic Medical Organization, 2018; $100,000). Role: Co-Investigator.

Cochrane Collaboration Complementary and Alternative Medicine Field: Resource for Research (NIH, 2018-2022: $250,000). Role: Co-Investigator.

Systematic Reviews with Network Meta-Analyses to Compare Interventions for Sudden Hearing Loss, Single Sided Deafness and Meniere's Disease (Canadian Institutes of Health Research, 2017: $245,000). Role: PI.
 
Application of network meta-analysis for assessment of pre-clinical/animal studies of interventions for stroke (Canadian Institutes of Health Research, 2016; $100,000). Role: Co-Investigator.

Sedation and delirium in the ICU: network meta-analyses of interventions (CIHR, 2015; $90,000). Role: Co-PI.

Expanding the Rethinking Clinical Trials (REaCT) Program in Ontario- a prospective study (Cancer Care Ontario, 2017-2019, $200,000). Role: Co-I. 

Randomised Study Comparing No Mechanical Bowel Preparation with Oral Antibiotics Alone in Patients Undergoing Elective Colon Surgery (The Ottawa Hospital Academic Medical Organization, 2018-19, $99,000). Role: Co-Investigator.

Systematic review and network meta-analysis of non-hormonal interventions for management of hot flashes in breast cancer and prostate cancer (CIHR, 2015, $100,000). Role: PI.

Canadian Institutes of Health Research/Drug Safety and Effectiveness Network Meta-Analysis Operating Grant (5 years, $7,000,000). Role: Co-Investigator.

Network Meta-Analysis of pharmacologic and non-pharmacologic alternatives for Attention Deficit Hyperactivity Disorder (Alicia Koplowitz Foundation, $43,000). Role: Co-Investigator.

Ottawa Hospital Research Institute (OHRI) – Evidence Review Synthesis Centre (Public Health Agency of Canada, 2015-17; $200,000). Role: Co-Investigator.

Canadian Institutes of Health Research/Drug Safety and Effectiveness Network New Investigator Award (2013-2018; $300,000). Role: PI.